Circadian expression of FGF21 is induced by PPARα activation in the mouse liver

FEBS Letters

Volumn 582, Issue 25-26, 2008, Pages 3639-3642

  Oishi, Katsutaka ^a   Uchida, Daisuke ^a,b   Ishida, Norio ^a,b  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Circadian rhythm; Fasting; FGF21; Fibrate; PDK4; PPAR

Indexed keywords

BEZAFIBRATE; FIBROBLAST GROWTH FACTOR 21; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; FGF21 GENE; GENE; GENE EXPRESSION; GENE INDUCTION; GENETIC ANALYSIS; LIVER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS;

ANIMALS; ANTILIPEMIC AGENTS; BEZAFIBRATE; CIRCADIAN RHYTHM; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION REGULATION; LIVER; MICE; MICE, KNOCKOUT; PPAR ALPHA; RNA, MESSENGER;

MUS;

EID: 53949110053     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2008.09.046     Document Type: Article

References (21)

1. Lefebvre P., Chinetti G., Fruchart J.C., and Staels B. Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis. J. Clin. Invest. 116 (2006) 571-580
2. Rakhshandehroo M., Sanderson L.M., Matilainen M., Stienstra R., Carlberg C., de Groot P.J., Muller M., and Kersten S. Comprehensive analysis of PPARalpha-dependent regulation of hepatic lipid metabolism by expression profiling. PPAR Res. 2007 (2007) 26839
3. Desvergne B., and Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev. 20 (1999) 649-688
4. Inagaki T., et al. Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metab. 5 (2007) 415-425
5. Reitman M.L. FGF21: a missing link in the biology of fasting. Cell Metab. 5 (2007) 405-407
6. Moore D.D. Physiology. Sister act. Science 316 (2007) 1436-1438
7. Itoh N., and Ornitz D.M. Evolution of the Fgf and Fgfr gene families. Trends Genet. 20 (2004) 563-569
8. Hsuchou H., Pan W., and Kastin A.J. The fasting polypeptide FGF21 can enter brain from blood. Peptides 28 (2007) 2382-2386
9. Chikahisa S., Tominaga K., Kawai T., Kitaoka K., Oishi K., Ishida N., Rokutan K., and Sei H. Bezafibrate, a PPARs agonist, decreases body temperature and enhances EEG delta oscillation during sleep in mice. Endocrinology 149 (2008) 5262-5271
10. Ptitsyn A.A., Zvonic S., Conrad S.A., Scott L.K., Mynatt R.L., and Gimble J.M. Circadian clocks are resounding in peripheral tissues. PLoS Comput. Biol. 2 (2006) e16
11. Stavinoha M.A., Rayspellicy J.W., Hart-Sailors M.L., Mersmann H.J., Bray M.S., and Young M.E. Diurnal variations in the responsiveness of cardiac and skeletal muscle to fatty acids. Am. J. Physiol. Endocrinol. Metab. 287 (2004) E878-E887
12. Oishi K., Shirai H., and Ishida N. CLOCK is involved in the circadian transactivation of peroxisome-proliferator-activated receptor alpha (PPARalpha) in mice. Biochem. J. 386 (2005) 575-581
13. Shirai H., Oishi K., Kudo T., Shibata S., and Ishida N. PPARalpha is a potential therapeutic target of drugs to treat circadian rhythm sleep disorders. Biochem. Biophys. Res. Commun. 357 (2007) 679-682
14. Galman C., et al. The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man. Cell Metab. 8 (2008) 169-174
15. Zhang X., et al. Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans. Diabetes 57 (2008) 1246-1253
16. Huang X., Yu C., Jin C., Yang C., Xie R., Cao D., Wang F., and McKeehan W.L. Forced expression of hepatocyte-specific fibroblast growth factor 21 delays initiation of chemically induced hepatocarcinogenesis. Mol. Carcinog. 45 (2006) 934-942
17. Badman M.K., Pissios P., Kennedy A.R., Koukos G., Flier J.S., and Maratos-Flier E. Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab. 5 (2007) 426-437
18. Lundasen T., Hunt M.C., Nilsson L.M., Sanyal S., Angelin B., Alexson S.E., and Rudling M. PPARalpha is a key regulator of hepatic FGF21. Biochem. Biophys. Res. Commun. 360 (2007) 437-440
19. Muise E.S., et al. Adipose fibroblast growth factor 21 is up-regulated by PPAR {gamma} and altered metabolic states. Mol. Pharmacol. 74 (2008) 403-412
20. Wang H., Qiang L., and Farmer S.R. Identification of a domain within peroxisome proliferator-activated receptor gamma regulating expression of a group of genes containing fibroblast growth factor 21 that are selectively repressed by SIRT1 in adipocytes. Mol. Cell Biol. 28 (2008) 188-200
21. Kersten S., Seydoux J., Peters J.M., Gonzalez F.J., Desvergne B., and Wahli W. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J. Clin. Invest. 103 (1999) 1489-1498